NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

HOPE-BAL: improved molecular diagnostics by application of a novel technique for fixation and paraffin embedding.

Author(s): Marwitz S, Abdullah M, Vock C, Fine JS, Visvanathan S, Gaede KI, Hauber HP, Zabel P, Goldmann T

Publication: J Histochem Cytochem, 2011, Vol. 59, Page 601-14

PubMed ID: 21430262 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine whether hepes-glutamic acid buffer mediated organic solvent protection effect (HOPE) fixation is a suitable alternative to formalin fixation or freezing for the preservation of protein and RNA.

Conclusion of Paper

HOPE-fixation yielded good morphological preservation and similar or superior immunostaining compared to formalin-fixation, depending on the antigen. Two-dimensional gel electrophoresis was possible with protein extracted from HOPE-fixed specimens. RNA with lower integrity was obtained from HOPE-fixed specimens compared to RNA from fresh-frozen specimens, and little to no detectable RNA was obtained from formalin-fixed specimens. Average RNA yields were 157 ng/uL, 138 ng/uL, and 3.2 ng/uL for frozen, HOPE-fixed, and formalin-fixed specimens, respectively. In situ hybridization, real-time qRT-PCR, and transcription microarray analysis were successfully performed using HOPE-fixed specimens.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of preservation method on immunohistochemical staining in bronchoalveolar lavage cells. Specimens fixed in 4% neutral buffered formalin were embedded in normal paraffin while HOPE-fixed specimens were embedded in low-melting point paraffin. The authors used both whole sections and tissue microarrays for immunostaining analysis.

    Summary of Findings:

    HOPE-fixation yielded good morphological preservation and CD8, CD68, Ki67, and pan-cytokeratin immunostaining was similar between HOPE-fixed and formalin-fixed specimens. However, HOPE-fixed specimens showed clear CD4 immunostaining while formalin-fixed specimens did not. Further, leukocyte common antigen (LCA) staining was superior in HOPE-fixed specimens compared to formalin-fixed specimens. Two-dimensional gel electrophoresis was possible with protein extracted from HOPE-fixed specimens.

    Biospecimens
    Preservative Types
    • Formalin
    • Other Preservative
    Diagnoses:
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Emphysema
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    Protein Immunohistochemistry
    Protein Tissue microarray
    Protein Colorimetric assay
    Protein 1D/2D gels
    Cell count/volume Light microscopy
    Morphology Light microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation Formalin (buffered)
    HOPE
    Preaquisition Diagnosis/ patient condition Tuberculosis
    Sarcoidosis
    Fibrosis
    Chronic cough
    Immunohistochemistry Specific Targeted peptide/protein CD4
    CD8
    CD68
    LCA
    Ki67
    Cytokeratins
  2. Study Purpose

    The purpose of this study was to determine the effects of preservation method (freezing at -80 degrees C, HOPE-fixation, or 4% neutral buffered formalin) on RNA yields and integrity in bronchoalveolar lavage cells.

    Summary of Findings:

    RNA with lower integrity was obtained from HOPE-fixed specimens compared to RNA from fresh-frozen specimens, and RNA integrity was unable to be determined for formalin-fixed specimens. RNA yields (4 specimens averaged) were 157 ng/uL, 138 ng/uL, and 3.2 ng/uL for frozen, HOPE-fixed, and formalin-fixed specimens, respectively. In situ hybridization, real-time qRT-PCR, and transcription microarray analysis were successfully performed using HOPE-fixed specimens.

    Biospecimens
    Preservative Types
    • Frozen
    • Other Preservative
    • Formalin
    Diagnoses:
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • Emphysema
    • Other diagnoses
    Platform:
    AnalyteTechnology Platform
    RNA In situ hybridization
    RNA Tissue microarray
    RNA Automated electrophoresis/Bioanalyzer
    RNA Electrophoresis
    RNA Real-time qRT-PCR
    Cell count/volume Light microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Preservation Type of fixation/preservation Formalin (buffered)
    Frozen
    HOPE
    Preaquisition Diagnosis/ patient condition Tuberculosis
    Sarcoidosis
    Fibrosis
    Chronic cough

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...